Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VAXiGEN alphavirus mRNA vaccine
- Development stage
- Preclinical
- Lead developer
- AlphaVax
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
01
Overview
VAXiGEN's alphavirus vaccine is an mRNA-based prophylactic candidate currently in the research and preclinical stages of development. Developed by the India-based biotech company VAXiGEN, the vaccine is designed to protect against infections caused by viruses in the *Alphavirus* genus, with a specific focus on Chikungunya and Ross River viruses. The platform utilizes messenger RNA (mRNA) to instruct host cells to produce viral antigens, thereby eliciting a targeted immune response. This candidate is part of VAXiGEN's broader effort to develop indigenous vaccine solutions using mRNA and surface display technologies for infectious diseases.
- Other names
- VAXiGEN alphavirus vaccineAlphavirus mRNA vaccine (VAXiGEN)
Beyond the preview
Go deeper on VAXiGEN alphavirus mRNA vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VAXiGEN alphavirus mRNA vaccine.